Navigation Links
Lo screening trial sul cancro al seno conclude che l'utilizzo della mammografia 3D in combinazione con un esame del seno 2D rileva un numero di tumori significativamente maggiore rispetto al solo esame del seno 2D
Date:1/17/2013

BEDFORD, Massachusetts, 17 gennaio 2013 /PRNewswire/ -- Hologic, Inc. (Hologic o la società) (NASDAQ: HOLX), leader nello sviluppo, nella produzione e nella fornitura di sistemi diagnostici e medici di acquisizione delle immagini e di prodotti chirurgici di alta qualità dedicati al servizio delle esigenze di salute delle donne, ha annunciato il 9 gennaio 2013 che un nuovo studio rivoluzionario, pubblicato su Radiology, la rivista scientifica della Radiological Society of North America, ha riscontrato che l'aggiunta all'esame 2D di screening al seno della tecnologia a tre dimensioni (3D) per la mammografia (tomosintesi al seno) di screening  aumenta in maniera significativa la rilevazione del cancro e riduce il numero di falsi positivi.

Lo studio, "Comparison of Digital Mammography Alone and Digital Mammography plus Tomosynthesis in a Population-based Screening Program" (Confronto della sola mammografia digitale con la mammografia digitale abbinata alla tomosintesi in un programma di screening sulla popolazione), è stato condotto da Per Skaane, M.D., Ph.D. dell'Ospedale Universitario Ullevaal di Oslo. Lo studio è stato basato su 12.631 esami di screening in un grande ospedale norvegese.

I ricercatori hanno riscontrato, mediante la tecnologia Hologic della mammografia 3D di in combinazione con una mammografia 2D, un notevole aumento nei tassi di rilevazione del cancro e una contemporanea diminuzione di falsi positivi rispetto alla sola mammografia 2D. Risultati importanti includono:

  • Un aumento del 40% nella rilevazione di cancri al seno invasivi
  • Un aumento del 27% nella rilevazione di tutti i cancri (invasivi e in situ)
  • Una riduzione del 15% nei falsi positivi

  • Gli autori hanno riferito che l'aumento nella rilevazione de
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
    2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
    3. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
    4. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
    5. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    6. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
    7. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
    8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
    9. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
    10. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
    11. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... 2015  A technique to increase the flow of blood ... blood pressure and red blood cell levels in preterm infants ... the National Institutes of Health. The study, published ... Research Institute at Sharp Mary Birch Hospital for Women and ... Linda University, Loma Linda, California . It ...
    (Date:6/29/2015)... , June 29, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, announced today ... with novel formulations of oral, enteric-coated buprenorphine (collectively ... pain and opioid dependence indications has reached the ... anticipates reporting top-line results in the second half ...
    (Date:6/29/2015)... BANGALORE and MOSCOW ... ReadSense, a genomics company at nanocenter TECHNOSPARK (Troitsk), ... the implementation of bioinformatics in personalized medicine, have ... Strand and ReadSense will jointly develop affordable tests ... of genetic pathologies such as hereditary forms of ...
    Breaking Medicine Technology:Umbilical cord 'milking' improves blood flow in preterm infants 2Umbilical cord 'milking' improves blood flow in preterm infants 3Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 2Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 3The Genomic Center of Nanocenters 'Technospark' and 'Dubna', Russia and Strand Life Sciences, India to Co-develop Tests for Diagnosis of Inherited Diseases 2The Genomic Center of Nanocenters 'Technospark' and 'Dubna', Russia and Strand Life Sciences, India to Co-develop Tests for Diagnosis of Inherited Diseases 3
    ... 2011 Four hospitals serving Virginia patients reduced healthcare-acquired ... days, resulting in savings of $1.2 million in additional ... persistent action plan to existing federal hand washing protocols, ... fewer infections and reduced patient length-of-stay and unnecessary readmissions. ...
    ... Pharmaceuticals, Inc., a publicly held corporation, (Symbol: PDRX.PK) ... an electronic medical record, from Wilson Medical Software, ... quality, low-cost tool for physicians to maintain patient ... and assistants to rapidly record visit notes and ...
    Cached Medicine Technology:Virginia Hospitals Reduce Infections 41% 2Virginia Hospitals Reduce Infections 41% 3PD-Rx Pharmaceuticals Acquires Wilson Medical's EMR 2
    (Date:6/29/2015)... ... June 29, 2015 , ... ... fellowship-trained spine surgeon, Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary ... California locations including Long Beach , Irwindale and La Tijera-Los Angeles. ...
    (Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... the news that the European Medicines Agency (EMA) has granted accelerated approval of ... remains a global public health threat and the approval of nivolumab for patients ...
    (Date:6/29/2015)... Chicago, IL (PRWEB) , ... June 29, 2015 ... ... engineer of patented products, announces the Fresh Plus Diaper, a baby invention that ... baby diaper market is projected to reach a market value of USD 52.2 ...
    (Date:6/29/2015)... ... June 29, 2015 , ... Two multicounty ... C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New Jersey’s ... Conference is to be convened on Thursday, July 23rd at 12:00 p.m. (In ...
    (Date:6/29/2015)... ... June 29, 2015 , ... OR Manager announced Monday ... look and feel, as well as a redesigned logo and weekly eLetter. The website ... is now more user-friendly and easier to navigate. , In addition to a ...
    Breaking Medicine News(10 mins):Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 2Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 5Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4Health News:OR Manager Launches New Website 2
    ... ... Management Market, NANJING, ... the manufacturer of the innovative,anti-cancer medication Endu and a leading ... that it has,entered into a definitive agreement to acquire a ...
    ... 28 ABR-Affinity,BioReagents, a leading global antibody ... Quality Guarantee. Launched in 2003, the ... confidence in research antibodies. Antibodies are,considered by ... early-stage life science,research and drug discovery. "Our ...
    ... (ALI) are nearly one-third less likely to die if they ... to oversee patient care, as compared to patients treated at ... case management. , ALI is an inflammatory disorder of ... Mortality rates are high -- about 40 percent -- and ...
    ... revered contemplative practice for centuries, meditation has recently ... from anxiety disorders to heart attack prevention. ... is associated with a high risk of depressiondouble ... estimatesand various forms of psychological distress. Increasingly, ...
    ... ones neighborhood are associated with greater asthma symptoms in ... , Social environment has long been thought to be ... few studies have empirically tested social factors at the ... childhood asthma. , Edith Chen, Ph.D., of the University ...
    ... herpesvirus (KSHV) is a human tumor virus and an ... endemic in sub-Saharan Africa where KS is nowadays the ... and human immunodeficiency virus (HIV). Importantly, KS also ... Helsinki, Finland, have discovered that activation of the DNA ...
    Cached Medicine News:Health News:Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd. 2Health News:Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd. 3Health News:Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd. 4Health News:ABR-Affinity BioReagents Expands 100% Quality Guarantee 2Health News:Acute lung injury patients one-third less likely to die in 'closed' model ICUs 2Health News:Acute lung injury patients one-third less likely to die in 'closed' model ICUs 3Health News:Meditation therapy for rheumatoid arthritis patients 2Health News:Meditation therapy for rheumatoid arthritis patients 3Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3Health News:DNA damage response confers a barrier for viral tumorigenesis 2
    The SonoSite MicroMaxx gives you big machine performance in a lightweight package. This laptop-sized, durable unit represents the technology crossover point between hand-carried ultrasound and larger...
    ... simple and flexible solution. The Coag-A-Mate ... design, but offers full automation and ... high-volume systems. It is an easy ... also be used as a back-up ...
    ... KeraCel Ophthalmic Products are ... formulation of lint-free MEROCEL polyvinyl ... configured to be beneficial to ... being absorbent, and yet firm ...
    ... a highly sharpened surgical blade that swings across ... produced is carefully controlled to a depth that ... located, but through the rich capillary bed. The ... significantly less pain and trauma to a babys ...
    Medicine Products: